| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $2,714.92 | $2,870.06 | $3,180.33 | |
BCBS
| Facility | $0.02 | $7,952.99 | $8,978.61 | |
United
| Professional | $1,628.95 | $2,327.07 | $5,593.89 |
Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient-specific panel for future comparisons to evaluate for MRD
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $2,714.92 | $2,870.06 | $3,180.33 | |
BCBS
| Facility | $0.02 | $7,952.99 | $8,978.61 | |
United
| Professional | $1,628.95 | $2,327.07 | $5,593.89 |